Evernorth announces another step forward in lowering drug prices by making a Stelara biosimilar available at $0 out of pocket for patients early next year.

The Evernorth Research Institute partnered with Ipsos to conduct a nationwide survey of benefit decision makers, health plan leaders, and consumers.

The latest international EVERNORTH HEALTH, INC. news and views from Reuters - one of the world's largest news agencies.

17 окт. 2024 г. · Transcarent, the One Place for Health and Care, was selected to power Evernorth Health Services' new Oncology Benefit Services program.

22 окт. 2024 г. · Evernorth says its Oncology Benefit Services will allow employers to provide a "streamlined" cancer care experience.

Evernorth Rural Ventures, a subsidiary of Evernorth, is pleased to announce the closing of $14.3 million in New Markets Tax Credit (NMTC) allocation.

Insurer Cigna's health services subsidiary Evernorth announced it acquired asynchronous platform Bright.md, which it will use to enhance the virtual care ...

17 авг. 2024 г. · The healthcare giant has kicked off operations of the new GCC with around 175 employees, with plans to grow the headcount to 1,000 techies in a ...

An Evernorth study found that in 2021, 25% of adults with ADHD did not receive any treatment, though this is a decrease from 38.5% in 2017.

10 сент. 2024 г. · Evernorth Health Services, a subsidiary of Cigna, plans to have a Stelara biosimilar available for $0 out-of-pocket cost for eligible patients of its specialty ...